Paul Sachs
- 48-week administration of olodaterol QD via Respimat® vs placebo and formoterol BID in patients with COPD: Pooled safety analysisBy Lorcan McGarvey, Andrea Koch, Paul Sachs, Alan Hamilton, Kay Tetzlaff, Lawrence Korducki and Gary FergusonLorcan McGarvey1Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, The Queen's University of Belfast, Belfast, United KingdomAndrea Koch2Medizinische Klinik III for Pneumology, Allergology and Sleep-Medicine, University Hospital Bochum-Bergmannsheil, Bochum, GermanyPaul Sachs3Pulmonary Associates of Stamford, Stamford, CT, United StatesAlan Hamilton4Boehringer Ingelheim, Burlington, ON, CanadaKay Tetzlaff5Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyLawrence Korducki6Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, United StatesGary Ferguson7Pulmonary Research Institute of Southeast Michigan, Livonia, MI, United States
- Lung function efficacy of olodaterol QD delivered via Respimat® in COPD patients: Results from two 48-week studiesBy Gary Ferguson, Gregory Feldman, Peter Hofbauer, Alan Hamilton, Lisa Allen, Lawrence Korducki and Paul SachsGary Ferguson1Pulmonary Research Institute of Southeast Michigan, Livonia, MI, United StatesGregory Feldman2South Carolina Pharmaceutical Research, Spartanburg, SC, United StatesPeter Hofbauer3Pneumologie-Weinheim, Weinheim, GermanyAlan Hamilton4Boehringer Ingelheim, Burlington, ON, CanadaLisa Allen5Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, United StatesLawrence Korducki5Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, United StatesPaul Sachs6Pulmonary Associates of Stamford, Stamford, CT, United States
- Comparing quality measures during hospitalization for chronic obstructive pulmonary disease in 2005-06 and 2010By Carrie P. Aaron, Natalie H. Yip, Marcia D. Brinson, Eliot Lazar, Brian Regan, Liziamma George, Marc S. Melamed, Paul Sachs, Maryanne Daley and Byron M. ThomashowCarrie P. Aaron1Department of Medicine, Columbia University, New York, NY,Natalie H. Yip1Department of Medicine, Columbia University, New York, NY,Marcia D. Brinson2Clinical Affairs and Quality Alliances, NewYork-Presbyterian Hospital, New York, NY,Eliot Lazar3Quality and Patient Safety, NewYork-Presbyterian Healthcare System, New York, NY,Brian Regan3Quality and Patient Safety, NewYork-Presbyterian Healthcare System, New York, NY,Liziamma George4Affiliated Hospital, NewYork-Presbyterian Healthcare System, New York, NY,Marc S. Melamed4Affiliated Hospital, NewYork-Presbyterian Healthcare System, New York, NY,Paul Sachs4Affiliated Hospital, NewYork-Presbyterian Healthcare System, New York, NY,Maryanne Daley4Affiliated Hospital, NewYork-Presbyterian Healthcare System, New York, NY,Byron M. Thomashow1Department of Medicine, Columbia University, New York, NY,
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
